γ-glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level

Abstract

Sepsis is a life-threatening organ dysfunction caused by dysregulated host response to infection and characterized by redox imbalance and severe oxidative stress. Glutathione (GSH) serves several vital functions, including scavenging free radicals and maintaining intracellular redox balance. Extracellular GSH is unable to be taken into the majority of human cells, and the GSH prodrug N-acetyl-l-cysteine (NAC) does not exhibit promising clinical effects. γ-glutamylcysteine (γ-GC), an intermediate dipeptide of the GSH-synthesis pathway and harboring anti-inflammatory properties, represents a relatively unexplored option for sepsis treatment. The anti-inflammatory efficiency of γ-GC and the associated molecular mechanism need to be explored. In vivo investigation showed that γ-GC reduced sepsis lethality and attenuated systemic inflammatory responses in mice, as well as inhibited lipopolysaccharide (LPS)-stimulated production of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), high-mobility group box 1 (HMGB1), and nitric oxide (NO) and the expression of inducible NO synthase and cyclooxygenase 2 in RAW264.7 cells. Moreover, both in vivo and in vitro experiments demonstrated that γ-GC exhibited better therapeutic effects against inflammation compared with N-acetyl-L-cysteine (NAC) and GSH. Mechanistically, γ-GC suppressed LPS-induced reactive oxygen species accumulation and GSH depletion. Inflammatory stimuli, such as LPS treatment, upregulated the expression of glutathione synthetase via activating nuclear factor-erythroid 2-related factor (Nrf2) and nuclear factor kappa B (NF-κB) pathways, thereby promoting synthesis of GSH from γ-GC. These findings suggested that γ-GC might represent a potential therapeutic agent for sepsis treatment.

Impact of Prolonged Mechanical Ventilation on Ferroptosis in Renal Ischemia/Reperfusion Injury in Rats

“…GSH is a tripeptide cellular antioxidant that protects the lipids, DNA, and proteins from oxidative damage [16]. Cellular GSH is typically depleted upon redox imbalance [17,18]. Pires et al [19] reported a significant reduction of GSH levels in the lung homogenates of MV group animals in comparison with the levels in a spontaneous respiration group.…”

Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice

“…To determine the regulatory role of Nrf2 in vivo , ML385 ( Nrf2 inhibitor; Medchem Express, Monmouth Junction, New Jersey, USA) was used to inhibit the Nrf2 expression in mice as previously described with the following modifications 34, 35. Mice received a daily intraperitoneal injection of ML385 (30 mg/kg) dissolved in PBS with 5% Dimethyl Sulfoxide (DMSO) for 7 d. On day 3 of ML385 injection, SE was induced followed by treatment with PBS or MSC-Exo treatment ML385+SE+PBS (n=5) and ML385+SE+Exo (n=5) groups, respectively.…”

Effect of (R)‐salbutamol on the switch of phenotype and metabolic pattern in LPS‐induced macrophage cells

“…Since glutathione (GSH) is a direct scavenger for excessive ROS. 38 The effect of (R)-salbutamol on intracellular GSH was also evaluated in this study. Intracellular GSH/GSSG ratios decreased to 70.60% of control levels when cells were induced with LPS, and the ratio…”